Ciesek, Sandra 1978-
Sandra Ciesek virologue allemande
VIAF ID: 313237361 ( Personal )
Permalink: http://viaf.org/viaf/313237361
Preferred Forms
- 100 1 _ ‡a Ciesek, Sandra ‡d 1978-
- 100 1 _ ‡a Ciesek, Sandra ‡d 1978-
- 100 0 _ ‡a Sandra Ciesek ‡c virologue allemande
4xx's: Alternate Name Forms (5)
5xx's: Related Names (12)
- 510 2 _ ‡a Enth. 4 Sonderabdr. aus verschiedenen Zeitschr
- 510 2 _ ‡a Georg-August-Universität Göttingen ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Goethe-Universität Frankfurt am Main ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Goslar ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 551 _ _ ‡a Hannover ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Klinik für Gastroenterologie, Hepatologie und Endokrinologie ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Klinik für Gastroenterologie, Hepatologie und Endokrinologie
- 510 2 _ ‡a Medizinische Hochschule Hannover
- 510 2 _ ‡a Medizinische Hochschule Hannover ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Twincore, Zentrum für Experimentelle und Klinische Infektionsforschung ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Twincore, Zentrum für Experimentelle und Klinische Infektionsforschung (Hannover)
- 510 2 _ ‡a Universität Duisburg-Essen ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q | |
Assessment of SARS-CoV-2 transmission on an international flight and among a tourist group | |
Berechnung, Analyse und Modellierung der Risiken transfusionsbedingter viraler Infektionen der Blutspendedienste des Deutschen Roten Kreuzes | |
CD47 as a potential biomarker for the early diagnosis of severe COVID-19 | |
Characterization of ACE inhibitors and AT1R antagonists with regard to their effect on ACE2 expression and infection with SARS-CoV-2 using a Caco-2 cell model | |
Characterization of antiviral effects of emricasan and SARS-CoV-2 isolates in vitro | |
Characterization of the filovirus-resistant cell line SH-SY5Y reveals redundant role of cell surface entry factors | |
Clinical and virological aspects of HBV reactivation: a focus on acute liver failure | |
Clinical performance of different SARS‐CoV‐2 IgG antibody tests | |
Comprehensive evaluation of hepatitis E serology and molecular testing in a large cohort | |
COVID-19 PHARMACOME: a method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization | |
COVID-19-related coagulopathy - is transferrin a missing link? | |
Definition einer minimalen Lipid-Droplet-Bindungsdomäne des Hepatitis-C-Virus Nichtstrukturproteins 5A | |
Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures | |
Development of antiviral strategies against positive-sense single stranded RNA viruses | |
Early Detection of SARS-CoV-2 Omicron BA.4 and BA.5 in German Wastewater | |
Einfluss eines Impfkurses auf Einstellungen und Wissen von Medizinstudierenden zum Thema Impfungen sowie deren Fähigkeiten im Umgang mit dem Impfpass | |
Einfluss von Amiodaron und anderer kationisch amphiphiler Pharmaka auf den Zelleintritt des Tollwutvirus | |
Environmental stability and infectivity of hepatitis C virus (HCV) in different human body fluids | |
Etablierung der Genomischen Erreger-Surveillance zur Stärkung des Pandemie- und Infektionsschutzes in Deutschland = Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany | |
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication | |
Die Hepatitis-C-Virusinfektion nach Lebertransplantation molekularvirologische Untersuchungen zur optimalen Immunsuppression | |
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study | |
Host cell mTORC1 is required for HCV RNA replication | |
Human mesenchymal stromal cells are resistant to SARS-CoV-2 infection under steady-state, inflammatory conditions and in the presence of SARS-CoV-2-infected cells | |
A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection | |
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform | |
Identification of Z-Tyr-Ala-CHN2, a cathepsin L inhibitor with broad-spectrum cell-specific activity against coronaviruses, including SARS-CoV-2 | |
Impact of host factor variation on the biology of HCV in vitro and in vivo | |
In vitro activity of itraconazole against SARS-CoV-2 | |
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants | |
Infectivity of deceased COVID-19 patients | |
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection | |
Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein | |
Low but recoverable markers of humoral immune response to BNT162b2 in elderly LTCF residents five to seven months after two-dose vaccination | |
Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020 | |
Novel multiple swab method enables high efficiency in SARS-CoV-2 screenings without loss of sensitivity for screening of a complete population | |
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes | |
Omicron-induced interferon signalling prevents influenza A virus infection | |
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response | |
Optimized qRT-PCR approach for the detection of intra- abd extra-cellular SARS-CoV-2 RNAs | |
Oxidized low-density lipoprotein is a novel predictor of interferon responsiveness in chronic Hepatitis C infection | |
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen Bedeutung für die Hepatitis-C-Virus-Infektion | |
Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) | |
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines | |
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies | |
Repurposing of the antibiotic nitroxoline for the treatment of mpox | |
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles | |
SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission | |
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment | |
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines | |
SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach | |
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination | |
SARS-CoV-2 variants show different host cell proteome profiles with delayed immune response activation in Omicron-infected cells | |
Self-collected samples to detect SARS-CoV-2: Direct comparison of saliva, tongue swab, nasal swab, chewed cotton pads and gargle lavage | |
Sofosbuvir activates EGFR-Dependent pathways in hepatoma cells with implications for liver-related pathological processes | |
Suitability of different diagnostic platforms for virological testing of blood samples from cornea donors | |
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants | |
Targeting the pentose phosphate pathway for SARS-CoV-2 therapy | |
Thirty years of CMV seroprevalence—a longitudinal analysis in a German university hospital | |
Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection | |
Untersuchung zur Beteiligung von Kindern in hessischen Kindertagesstätten am Infektionsgeschehen während der SARS-CoV-2-Pandemie: Ergebnisse der SAFE-KiDS-Studie | |
Yellow fever: Integrating current knowledge with technological innovations to identify strategies for controlling a re-emerging virus |